Victor
Vanbremeer­sch

There is a specific kind of person the venture capital world produces that has no clean name yet. Not a founder who took VC money. Not a VC who went back to build something. Something stranger: a person doing both simultaneously, holding a founder's equity in one hand and a Scout's carry in the other, writing checks into other people's startups while also cashing other people's checks into his own. Victor Vanbremeersch is that person, and the arrangement is more coherent than it sounds.

He landed in San Francisco with a management degree from emlyon business school in Lyon, France - a triple-accredited institution most Americans have never heard of - and a stint in finance at HSBC. Neither credential was especially unusual. What was unusual was what he built after leaving the comfort of the banking corridor.

Moona Health is an AI-powered platform for treating insomnia using CBT-I - Cognitive Behavioral Therapy for Insomnia - a method the American College of Physicians considers the gold-standard first-line treatment for chronic insomnia, and one that a remarkable number of Americans have never been offered. Most people reaching for a sleep aid are reaching for the wrong thing. Not because their doctors are incompetent, but because CBT-I therapists are scarce, expensive, and rarely covered by insurance. Moona Health is betting those three problems are one problem, and that software can solve it.

The bet attracted $3.7 million from a group that includes Andreessen Horowitz, Heuristic Capital Partners, Kima Ventures, and Liberty Equity Management. It also landed Moona Health a spot in a16z Speedrun Cohort 005, the accelerator program that the firm runs for companies it considers genuinely early and genuinely interesting. The cohort is small on purpose.

What makes Victor's position structurally odd - and somewhat telling about how a16z operates at its edges - is that he didn't just take money from a16z. He joined the Scout program, which means he's now identifying other early-stage companies for the firm to look at. He carries an @a16z.com email address. He sits in both chairs.

This is not a conflict. It's a feature. The scout program at a16z operates on the logic that the people best positioned to find the next interesting company are those currently building one - they're inside the rooms, on the Discord servers, at the dinners where companies begin. Victor is one of those people. He knows what the early days of a health startup look like because he's living them.

The market he's targeting is not small. Women experience insomnia at roughly twice the rate of men - a statistic that Moona Health has built into its product focus from day one. The company is not trying to treat everyone who can't sleep. It's building the largest virtual network of CBT-I therapists specifically designed to accept insurance, specifically focused on women's sleep patterns, and specifically designed to be accessible without a prescription or out-of-pocket thousands.

Victor co-founded Moona Health alongside Paul Deschamps. The clinical partnership with BlueSleep - announced in 2025 - extended that reach further, connecting Moona's platform to an established sleep health network with existing patient relationships and diagnostic infrastructure. The partnership is a smart move for a startup: rather than building a patient pipeline from scratch, you plug into one that exists.

He is, by any measure, an early-career founder. Entry-level in title, not in ambition. The arc from a French business school to a16z Scout to healthcare startup CEO in under five years is not an arc that comes from following a roadmap. It comes from building in places where the map hasn't been drawn yet.

The sleep market, despite its size, remains remarkably underdeveloped. Most of the capital has gone to tracking - apps that measure your sleep stages, devices that count your REM cycles - rather than treating the underlying disorder. Victor's argument is that measurement without treatment is noise. Moona Health is the treatment layer.